VITASPRING BIOMEDICAL CO. LTD. replaced Ssu-Chuan Lai with Jing-Zhou Chen as chief executive, president, chief financial officer and secretary, while Shao-Hsiang Shih became chairman. The change gives investors identified leaders for executive management and board oversight, with neither appointee receiving compensation unless the board later determines otherwise.

Key Highlights

  • Jing-Zhou Chen became VITASPRING’s chief executive, president, chief financial officer and secretary.
  • Shao-Hsiang Shih was elected as a director and appointed chairman.
  • Ssu-Chuan Lai’s resignation letter.

VITASPRING BIOMEDICAL CO. LTD. (OTC: VSBC) completed a Leadership transition on September 7, 2026, with Ssu-Chuan Lai leaving her executive and board positions. Jing-Zhou Chen assumed the company’s top executive and financial roles, while Shao-Hsiang Shih took the chairmanship. The appointments followed the election of a successor director.

Chen Takes Executive and Financial Roles

Chen was appointed chief executive officer, president, chief financial officer and secretary. The board also designated him principal executive officer, principal financial officer and principal accounting officer. Chen holds a bachelor’s degree in electrical engineering and is enrolled in an executive master’s program in information and financial management.

Shih Assumes Board Chairmanship

He has served as director of administrative management at Century Publishing Co. since 2020 and previously held its education-management role. Shih also worked at Century Education Center and holds degrees from National Taipei University and Fo Guang University. The board cited his management, administrative and Taiwan Business experience when selecting him. Lai’s resignation was stated not to result from disagreement with VITASPRING over operations, policies or practices. Her resignation letter. The board authorized indemnification agreements for Chen and Shih, although those agreements had not been executed as of the report date.